Details for Patent: 7,027,859
✉ Email this page to a colleague
Summary for Patent: 7,027,859
Title: | Electrotransport delivery device having improved safety and reduced abuse potential |
Abstract: | An electrotransport device (20) for delivering one or more therapeutic agents through the skin includes electrodes (30,32) for contacting the skin (34), at least one electrode containing the agent, a power source (22) for generating electrical current (I.sub.L) for delivering the agent, a current generating and controlling means (24), and a disabling means (26) for permanently and irreversibly disabling the current. The disabling means (26) may include a timer means (66), a counter means (82), or a body parameter sensor (134) and limit comparator (132) to effect permanent disabling. The disabling means may be a permanent transition to a disabled logic state, a permanent discharge of a power supply source (22), or a permanent diversion of electrotransport current from the electrodes (30,32), or a combination of the above. The permanent disabling means may include a circuit connection means (304,308,326,328) having a frangible conducting member (332) which permanently fractures and causes an irreversible open circuit in the connection to the electrodes (334,342) upon removing a disposable/single use electrode assembly (300) from a reusable portion of an electrotransport device. |
Inventor(s): | McNichols; Larry A. (Coon Rapids, MN), Badzinski; John D. (Coon Rapids, MN), Reining; William N. (Cross Plains, WI), Lattin; Gary A. (Forest Lake, MN), Haak; Ronald P (Menlo Park, CA), Phipps; Joseph B. (Plymouth, MN) |
Assignee: | ALZA Corporation (Mountain View, CA) |
Application Number: | 08/312,336 |
Patent Claim Types: see list of patent claims | Delivery; Device; Use; |
Drugs Protected by US Patent 7,027,859
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,027,859
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 173942 | ⤷ Try a Trial | |||
Australia | 3594095 | ⤷ Try a Trial | |||
Canada | 2195657 | ⤷ Try a Trial | |||
Germany | 69506426 | ⤷ Try a Trial | |||
Denmark | 0781152 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |